Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 5 | 2024 | 287 | 1.800 |
Why?
|
| Neoplasms | 7 | 2024 | 3065 | 1.070 |
Why?
|
| Lung Neoplasms | 4 | 2023 | 2370 | 0.850 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 755 | 0.830 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 112 | 0.750 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2021 | 17 | 0.740 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2021 | 63 | 0.720 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 521 | 0.640 |
Why?
|
| MicroRNAs | 1 | 2023 | 556 | 0.620 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1131 | 0.550 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 598 | 0.510 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 980 | 0.500 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 1098 | 0.450 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 1061 | 0.440 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 3022 | 0.310 |
Why?
|
| Humans | 19 | 2024 | 89970 | 0.270 |
Why?
|
| Motor Neuron Disease | 2 | 2014 | 21 | 0.240 |
Why?
|
| Neoplasm Metastasis | 3 | 2024 | 1066 | 0.230 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2023 | 26 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 65 | 0.220 |
Why?
|
| Rectal Neoplasms | 1 | 2024 | 129 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 98 | 0.210 |
Why?
|
| Radiation Pneumonitis | 1 | 2022 | 21 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 476 | 0.200 |
Why?
|
| Fluorouracil | 1 | 2023 | 549 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 183 | 0.180 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 2000 | 0.170 |
Why?
|
| Retrospective Studies | 3 | 2023 | 9210 | 0.170 |
Why?
|
| Motivation | 1 | 2022 | 296 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 399 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 436 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 422 | 0.140 |
Why?
|
| Mass Screening | 1 | 2021 | 647 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1352 | 0.130 |
Why?
|
| Cerebellum | 2 | 2014 | 250 | 0.130 |
Why?
|
| Neural Pathways | 2 | 2014 | 319 | 0.130 |
Why?
|
| Combined Modality Therapy | 3 | 2024 | 1704 | 0.130 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2014 | 25 | 0.120 |
Why?
|
| Brain Mapping | 2 | 2014 | 570 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2014 | 59 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2014 | 81 | 0.110 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 591 | 0.110 |
Why?
|
| Female | 6 | 2024 | 46595 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 2506 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2014 | 188 | 0.100 |
Why?
|
| Nerve Net | 1 | 2014 | 375 | 0.090 |
Why?
|
| Middle Aged | 4 | 2024 | 26148 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2024 | 4331 | 0.090 |
Why?
|
| Male | 5 | 2024 | 42682 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2022 | 698 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3475 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2024 | 310 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2024 | 152 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 269 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2022 | 60 | 0.050 |
Why?
|
| Disease Management | 1 | 2024 | 327 | 0.050 |
Why?
|
| Immune System | 1 | 2022 | 97 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 124 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 583 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2014 | 17 | 0.030 |
Why?
|
| Pons | 1 | 2014 | 25 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 31 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 63 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 71 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2655 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6783 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8273 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2677 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1250 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 696 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7108 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3773 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19254 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 26822 | 0.010 |
Why?
|
| Child | 1 | 2014 | 7244 | 0.010 |
Why?
|